Who founded Curebase?

Curebase was founded by Storm Stillman, Tom Lemberg in 2017.

Who are Curebase's investors?

Curebase's investors include Acrew Capital, Bold Capital Partners, Breyer Capital, C3 Ventures, Future Planet Capital, Gaingels, Mount Pleasant Ventures, Notable Capital and 14 more.

How much funding has Curebase raised?

Curebase has disclosed $58.9M raised across 3 of its 4 known rounds.

Where is Curebase headquartered?

Curebase is headquartered in Fort Lauderdale, US.

Curebase

YC S18

Fort Lauderdale, US · Founded 2017 · Delaware corporation · 27 employees · 23 known investors

Find your way into Curebase

Paths you didn't know you had: your email and LinkedIn already hold routes to the Curebase team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Curebase provides a software platform for clinical trial management, serving contract research coordinators and trial sites. The platform emphasizes modern technology, data integrity, and compliance for advancing medical research.

Also known as tlemberg

AI & Machine Learning Biotech Digital Health Healthtech SaaS HealthcareUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (S18)

Curebase was founded in 2017 by Storm Stillman and Tom Lemberg.

Storm Stillman Co-founder · Chief Executive OfficerStorm Stillman co-founded and led Luminist Labs, which was acquired by DiscernDx, and currently serves as CEO of Curebase.

Tom Lemberg Founder & CEO2017–2025Tom Lemberg is the founder and CEO of Curebase, a clinical trial management software platform serving contract research coordinators and trial sites.30 Under 30 2022

Marissa MundRecruiting Sourcer and Coordinator

Patrick AustermannVice President of Engineering and Product

Rein OterholmTech Lead / Manager

Matthew RialsCTOformer

Noah Debrincat Lead Product ManagerFounder at Zergo

Hannah GittlemanHead of Peopleformer

Sam OliverLead Recruiterformer

Investors · 23

Acrew Capitallisted by Acrew CapitalSan Francisco · $1M – $15M

How we know: Acrew Capital's portfolio page · prnewswire.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Bold Capital Partnerslisted by Bold Capital PartnersSanta Monica

How we know: Bold Capital Partners's portfolio page · prnewswire.com · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Breyer Capitallisted by Breyer CapitalAustin · $500K – $10M

How we know: Breyer Capital's portfolio page · the VCSheet dataset · Not right? Tell us

C3 Ventureslisted by C3 VenturesLos Angeles

How we know: C3 Ventures's portfolio page · a partner's Signal profile · Not right? Tell us

Future Planet Capitallisted by Future Planet CapitalLondon

How we know: Future Planet Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: prnewswire.com · Y Combinator's founder network · gaingels.com · Not right? Tell us

Mount Pleasant Ventureslisted by Mount Pleasant VenturesWashington

How we know: Mount Pleasant Ventures's portfolio page · Not right? Tell us

Notable Capitallisted by Notable CapitalSilicon Valley · $5M – $50M

How we know: Notable Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Pascal Capitallisted by Pascal Capital

How we know: Y Combinator's founder network · Not right? Tell us

Pioneerlisted by PioneerToronto, Ontario

How we know: Y Combinator's founder network · pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us

StartXlisted by StartXStanford · $10K – $1M

How we know: StartX's portfolio page · Not right? Tell us

Xfundlisted by XfundPalo Alto · $50K – $500K

How we know: Xfund's portfolio page · a partner's Signal profile · prnewswire.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

GGV CapitalreportedMenlo Park

How we know: prnewswire.com · Not right? Tell us

GGV DiscoveryreportedGrand Cayman

How we know: Y Combinator's founder network · Not right? Tell us

Gilead SciencesreportedFoster City

How we know: prnewswire.com · Y Combinator's founder network · Not right? Tell us

Industry VenturesreportedSan Francisco · $250K – $50M

How we know: prnewswire.com · Y Combinator's founder network · Not right? Tell us

Liquid VenturesreportedSan Francisco · $250K – $5M

How we know: Y Combinator's founder network · open dataset · 5k.vc investor directory · Not right? Tell us

Positive Sum CapitalreportedGreenwich · $5M

How we know: Y Combinator's founder network · Not right? Tell us

SynetroreportedChicago · $1M

How we know: Y Combinator's founder network · Not right? Tell us

World Innovation LabreportedPalo Alto

How we know: prnewswire.com · Not right? Tell us

World Innovation Lab (WiL)reportedPalo Alto · $5M – $30M

How we know: Y Combinator's founder network · open dataset · 5k.vc investor directory · Not right? Tell us

Also in the syndicate · 1

Positive Sum

Funding

SEC filings, press & company announcements

$58.9M disclosed across 3 of 4 rounds · 2018–2022

$40MSeries BMay 2022 · 2 sources
Industry Ventures (lead), Acrew Capital, Bold Capital, Gaingels, GGV Capital, Gilead Sciences, Positive Sum, World Innovation Lab, Xfund
Source ↗

▶$16.4MraisedJul 2021 · 19 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Jeff RichardsDirector
Thomas LembergExecutive Officer, Director, Promoter

Offering amount: $16.4M
Amount sold: $16.4M
First sale: Apr 2021
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.5MraisedNov 2018 · 18 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Thomas LembergExecutive Officer, Director

Offering amount: $2.5M
Amount sold: $2.5M
First sale: Oct 2018
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Curebase went on to found or lead other companies.

Storm StillmanCOOFounded Luminist Labs Noah DebrincatLead Product ManagerFounded Zergo

Related companies · 10

TriomicsTriomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation. The company serves oncology clinics, trial matching networks, and quality reporting teams.

MedidataMedidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.

MicrohealthMicrohealth builds digital tools that connect patients with healthcare professionals outside clinical settings to improve treatment outcomes and enable patient engagement. The company serves patients, healthcare professionals, patient organizations, and medical organizations across specialty care.

PowerPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.

GenomelinkGenomelink develops a platform that provides individuals with access to and management of their genomic data, leveraging advances in DNA sequencing technology. The company serves consumers seeking personal genetic information and operates in the genomics and digital health sector.

AdvarraAdvarra provides clinical research services and technology, including institutional review board (IRB) and institutional biosafety committee (IBC) review, data monitoring, endpoint adjudication, and consulting, along with software platforms for clinical trials. It serves life sciences companies, research sites, and institutions in the clinical research industry.

DelineateDelineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Encepheal TherapeuticsEncepHeal develops small-molecule medications targeting the dopamine transporter to treat stimulant addiction, including cocaine and methamphetamine, for which no FDA-approved treatments currently exist. The company uses allosteric modulators designed to reduce drug cravings without the addictive potential of earlier dopamine-targeting approaches.

VeevaVeeva Clinical Platform is a cloud-based suite of connected applications for running clinical trials, covering clinical operations, clinical data, research sites, and patients. It serves biopharma sponsors, clinical research sites, and patients across trial management, data capture, and disclosures.

Companies working in the same space as Curebase.

Legal entities · 1

corporate structure

Curebase, Inc.

In the news

Meet Two New Additions to the Curebase Advisory Team | Curebase Newscurebase.ai · May 2025

Curebase Announces Important Leadership Update | Curebase Newscurebase.ai · Apr 2025

Frequently asked questions

What does Curebase do?: Curebase provides a software platform for clinical trial management, serving contract research coordinators and trial sites. The platform emphasizes modern technology, data integrity, and compliance for advancing medical research.
Who founded Curebase?: Curebase was founded by Storm Stillman, Tom Lemberg in 2017.
Who are Curebase's investors?: Curebase's investors include Acrew Capital, Bold Capital Partners, Breyer Capital, C3 Ventures, Future Planet Capital, Gaingels, Mount Pleasant Ventures, Notable Capital and 14 more.
How much funding has Curebase raised?: Curebase has disclosed $58.9M raised across 3 of its 4 known rounds.
Where is Curebase headquartered?: Curebase is headquartered in Fort Lauderdale, US.